Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Angel Investors in United Kingdom in May 2025

Last updated: May 2025 A list of 50 angel investors that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.

Top 50 Medical Angel Investors in United Kingdom in May 2025

Investor	Medical United Kingdom investments
Jonathan Milner	12
Ian Hogarth	3
Will Martin	2
Matt Robinson	2
Matt Clifford	2
Alexander Edward Chesterman	2
Mark Bamforth	2
Nicholas Edwards	2
Ariel Poler	2
Taavet Hinrikus	2
Michael Pennington	2
Will Brooks	2
Jan Hruska	2
Yusuf Hamied	1
Jon Moulton	1
Arjun Desai	1
Mark Cuban	1
Paul Thandi	1
Duncan Grierson	1
Nadav Rosenberg	1
Paul Roy	1
Richard Reed	1
Carlos Gallardo	1
Bashar Hamood	1
Jonathan Lenson	1
Brian Souter	1
Errol Damelin	1
Stephen Bourke	1
Maurice Ferre, M.D.	1
Bob Davis	1
Thomas Dyrberg	1
John Lloyd	1
Jim Breyer	1
Peter Job	1
Flavien Kulawik	1
Michael Bibby	1
Pa Nolan	1
Arthur Chen	1
Emilio Püschmann	1
Simon Kruger	1
Amar Shah	1
Phil Kirby	1
Tracy Doree	1
Catherine Lenson	1
Evelyn Bourke	1
Roger Hassan	1
Jim Mellon	1
Dieter Spälti	1
Nicolaus Henke	1
John Taysom	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.

Will Martin - Founder and Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

Investment focus

Software, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Malga — Malga is an online payment platform that offers fraud protection and payment split services.
Kaedim — Kaedim’s product creates 3D content as easily as you can take a photo, 2D content, with your smartphone today.
Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, India, United States

Portfolio highlights

Stackfix — Stackfix operates as a software comparison platform.
Patch — Patch is your new neighbourhood space for work, community, and events.
Flow Engineering — Requirements management, made collaborative

Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.

Investment focus

E-Commerce, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, France

Portfolio highlights

Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Health Care, Medical, Biotechnology
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Mexico, United Kingdom

Portfolio highlights

Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
Reloadly — Unlock global access with Reloadly's powerful API for digital gift cards and mobile top- ups.Simplify payouts, boost engagement, and grow your business with customizable, easy- to - integrate solutions.
Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.

Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.

Investment focus

FinTech, Software, Financial Services
Seed, Series A, Series B
United Kingdom, United States, Estonia

Portfolio highlights

Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

Investment focus

Software, SaaS, Financial Services
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Spain

Portfolio highlights

Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
FUEL — Where everlasting fanbases are built
Sidekick — Expertly-managed portfolios for the modern investor

Will Brooks - Founder & Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

Jan Hruska

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.

Investment focus

Financial Services, FinTech, Banking
Funding Round, Seed, Series A
United Kingdom, Cyprus, Luxembourg

Portfolio highlights

Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.

Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Blockchain, Software, E-Commerce
Seed, Series A, Angel
United States, Vietnam, Singapore

Portfolio highlights

Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
Allstar — Free, fast, and easy clip capture with zero FPS drop for Counter-Strike 2, League of Legends, Fortnite, and Dota 2.
Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.

Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Duncan Grierson

Investment focus

Water, Medical, CleanTech
Seed, Series A
United Kingdom

Portfolio highlights

Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Pharmaceutical
Seed, Pre-Seed, Series A
United Kingdom, Israel, Singapore

Portfolio highlights

thymia — Making mental health as objectively measurable as physical health.
Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.

He was a founding partner and chairman of NewSmith Asset management, a fund manager for a wide range of institutional, pension fund and high net worth investors. Having started his career at the stockbroking firm Kemp Gee he subsequently became senior partner following the merger with Scrimgeour Vickers and Citibank. In 1988 he joined Smith Newcourt, the leading market making firm on the London Stock Exchange and as CEO, together with chairman Michael Marks merged the business with Merrill Lynch in 1995. At Merrill, Paul held a number of senior positions including head of Global Equities and in 2001 was made EVP and president of Merrill Lynch Global Markets and investment banking, responsible for the firm’s investment banking, debt and equity business worldwide. He left Merrill in 2003 to start NewSmith.He has served as a non executive director of Benfield plc and Cenkos securities and is currently Chairman of New River Retail plc the leading UK REIT specialising in retail property investment.Between 2007 and 2013 Paul served two terms as Chairman of the newly created British Horse Racing Authority, responsible for the Governance and Regulation of the country’s second largest sport. He is now Chairman of ROR, the sports main charity, responsible for ensuring that horses are cared for, retrained, and re-homed, after their racing careers are over. He has a Bachelor of Arts (Honours) degree in Economics from Liverpool University and in 2009 was awarded an Honoury Doctorate of Law from Liverpool University.

Investment focus

Fitness, Medical, Wellness
Seed
United Kingdom

Portfolio highlights

Qured — Get affordable and reliable PCR Fit to Fly tests and Antigen Fit to Fly tests from Qured. Fast results. Recommended by global airlines, UKAS accredited.

Richard is the founder of Innocent Drinks, UK's number 1 smoothie brand. In 2009 The Coca-Cola Company acquired a minority stake in Innocent Drinks and in 2013 the stake was increased to over 90%. Innocent Drinks gives 10% of its profits to charity. Richard is known to have implemented a google-like working atmosphere at InnocentDrinks' offices, where people feel like at home. He appeared in sereval high profile TV shows and documentaries, here is a documentary with Peter Jones from Drangon's Den (UK's equivalent of Shark Tank) He is now a successful investor through his company JamJar Investments, where they invest in strong teams with an idea that consumers love.

Investment focus

Content, Food and Beverage, Pharmaceutical
Seed, Series A, Funding Round
United Kingdom, United States

Portfolio highlights

Simba Sleep — One Mattress. Five Layers of Comfort. Tailored to Suit All. Bringing together experience & technology so that your mattress gives you the best night's sleep.
Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
Beckley Canopy Therapeutics — Beckley Canopy Therapeutics is a biopharmaceutical company designed to research cannabis health products.

Carlos Gallardo

Investment focus

Health Care, Medical Device, Medical
Seed, Series A
Spain, United Kingdom

Portfolio highlights

Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Bashar Hamood is a result oriented professional with versatile experience across diverse organizational domains. He is well versed in the development of marketing strategies, branding, direct marketing, new products/brands launches, analysis, reporting, and positioning.He is an entrepreneur and self-starter with expansive experience in brandawareness and development, community outreach.Bashar is a versatile business manager with proven competencies in optimizing team dynamics uniting diverse agenda to common goal and harnessing strategic and operational drivers to deliver results.He has a strong analytical mind with rigorous study for each case and the output of each variation for each parameter.Bashar loves to take risk and new challenges.

Investment focus

Information Technology, Software, Mobile Apps
Seed, Pre-Seed, Angel
United States, India, United Arab Emirates

Portfolio highlights

Safedeploy — Fault free software update platform for tracking your software reliability in real time for every device and every software application
Event Arena — Event Arena organizes events, corporate events, conferences, sales promotions, and presentations.
Palacio Inc. — Palacio Inc. aims to inspire every living space through innovation in art and technology. Our first product Canvia is a revolutionary content platform for art and photography, which utilizes patented technology for a seamless and authentic experience in any environment. We bring content from leading contemporary creators and world class culturalinstitutions into our living spaces like never before.

Jonathan Lenson

Investment focus

Software, Information Technology, Internet
Seed, Grant, Pre-Seed
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.

Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.

Investment focus

Medical, Commercial, Health Care
Funding Round
United Kingdom

Portfolio highlights

Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.

Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal. Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.

Investment focus

FinTech, Financial Services, Finance
Seed, Series A, Pre-Seed
United Kingdom, United States, Israel

Portfolio highlights

Zelt — Manage everything from HRIS, payroll, pension, devices, apps and more seamlessly in one central hub, for all processes and applications, third-party included. Improve productivity through enhanced employee experience.
Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback

Stephen Bourke

Investment focus

Health Care, Medical, Wellness
Pre-Seed, Angel
United Kingdom

Portfolio highlights

Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
Habitual — Our diabetes remission programme combines digital therapeutics with diet and habit change. Our personalised programme delivers type 2 diabetes reversal and weight loss.
Syndi Health — Meet Syndi Health: an all-in-one platform for aggregating, recommending, and paying for digital health services - amplifying your employee wellbeing support with 0% admin.

Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.

Investment focus

Medical Device, Medical, Health Care
Series A, Seed, Angel
United States, United Kingdom

Portfolio highlights

Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

Investment focus

Internet, Advertising, Social Network
Series A, Series B, Series C
United States, United Kingdom

Portfolio highlights

LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.

Thomas P. Dyrberg, M.D., Ph.D., serves as Senior Partner of Novo Ventures and Novo A/S. Thomas Dyrberg joined Novo A/S in December 2000, where he was a Partner.He held research positions at the Hagedorn Research Institute, Gentofte, Denmark and at the Scripps Research Institute, La Jolla, California.In 1990, he joined Novo NordiskA/S and worked in health care discovery on various aspects of diabetes immunology and pathogenesis and health Care Clinical Drug Development as an International Clinical Project Manager since 1996. He serves as the Deputy Chairman of Veloxis Pharmaceuticals A/S and has been its Director since September 2003.Thomas Dyrberg has been a Director at Gloucester Pharmaceuticals, Inc. since August 25, 2009. He serves as a Director at Rejuvenon, Corp, Allocure Inc., Veloxis, Lux Biosciences, Inc., Ophthotech Corporation, Sapphire Therapeutics Inc., and Delenex Therapeutics AG.He served as a Director of BioMimetic Therapeutics, Inc. from May 2001 to June 21, 2007. He served as a Director of Helsinn Therapeutics (U.S.), Inc. He has published several articles within the fields of diabetes, immunology, and autoimmunity.Thomas Dyrberg has an M.D. degree in 1981 and his DM.Sc. degree from the University of Copenhagen in 1986.

Investment focus

Biotechnology, Medical, Health Care
Series B, Series C, Seed
United States, United Kingdom, Switzerland

Portfolio highlights

PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases

John Lloyd

Investment focus

Health Care, Education, Wellness
Seed, Funding Round, Equity Crowdfunding
United Kingdom

Portfolio highlights

Thrive — Thrive Mental Wellbeing - Mental Health Services
Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.

Jim Breyer - Co-Founder @ Accel-KKR

Investment focus

Health Care, Software, Information Technology
Series B, Series A, Series C
United States, United Kingdom, Singapore

Portfolio highlights

Zeck — Create smarter, modern board updates optimized for superior readability to better engage and inform your board and investors. Run perfect board meetings.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.

Peter Job is an angel investor.

Investment focus

Medical, Software, Pharmaceutical
Funding Round
United Kingdom

Portfolio highlights

Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.

Flavien Kulawik

Investment focus

Health Care, Artificial Intelligence, SaaS
Seed, Funding Round, Series A
France, United Kingdom

Portfolio highlights

Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Scienta Lab — Redefining precision immunology

Michael Bibby is Chairman at Bibby Line Group Ltd.

Investment focus

Medical, Hospital, Medical Device
Seed
United Kingdom

Portfolio highlights

AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

Pa Nolan

Investment focus

Medical, Delivery, Shipping
Seed, Funding Round
Ireland, United Kingdom

Portfolio highlights

SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.

Arthur Chen is a Managing Partner at Ameba Capital.

Investment focus

Medical, Chemical, Software
Series A, Funding Round
United Kingdom

Portfolio highlights

Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.

Emilio Püschmann

Investment focus

Medical, Database, Consulting
Pre-Seed
United Kingdom

Portfolio highlights

OPEN Health — OPEN Health is a medical affairs partner providing HEOR, market access, medical communication and omni campaign consulting services.

Simon Kruger

Investment focus

Medical, Database, Consulting
Pre-Seed
United Kingdom

Portfolio highlights

OPEN Health — OPEN Health is a medical affairs partner providing HEOR, market access, medical communication and omni campaign consulting services.

Amar is an Entrepreneur in Residence at firstminute focusing on ML and AI technologies. Most recently Amar was CEO and co-founder of Wayve, a company developing an end-to-end machine learning stack for self-driving cars. He was responsible for raising $40 million and building a team of 60 world-class engineers in the UK. Previously Amar has been aQuantitative Strategist at Goldman Sachs, and subsequently completed a PhD in Machine Learning at the University of Cambridge working with Prof Zoubin Ghahramani and Prof Yoshua Bengio, the 2018 winner of the Turing Award. Amar's research was awarded the European Qualcomm Innovation Fellowship in 2015 and the EPSRC Doctoral Prize in 2016. Amar has also applied Machine Learning to the Grand Asteroid Challenge at NASA, where his project was presented in the White House and he won a Planetary Defense Award.

Investment focus

Artificial Intelligence, Health Care, Software
Pre-Seed, Seed, Angel
United Kingdom, Germany, United States

Portfolio highlights

Fractile — Fractile is building chips to run large language models two orders of magnitude faster. Existing hardware is good for training LLMs, but very poorly suited to subsequent inference of the trained model, which is increasingly the dominant workload. A network’s weights need to be moved onto a chip once per word generated, and this movement takes a fewhundred times longer than the subsequent computations themselves. Fractile’s revolutionary approach to fusing computation with memory eliminates this bottleneck, and can scale to allow running the world’s largest models at a global scale.
Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
Martian Lawyers Club — Home of GUG and Starships TV

Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.

Investment focus

Medical, Hospital, Medical Device
Seed
United Kingdom

Portfolio highlights

AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.

Investment focus

FinTech, Medical, Wellness
Seed, Pre-Seed
United Kingdom

Portfolio highlights

Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
Nosso — Nosso is a mobile-based financial planning platform for the future of children.
The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)

Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.

Investment focus

Software, Information Technology, Internet
Seed, Pre-Seed, Grant
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.

Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.

Investment focus

InsurTech, Insurance, Software
Seed, Pre-Seed, Series B
United Kingdom

Portfolio highlights

Hybr — Find your next student accommodation with Hybr, the UK's best student letting platform. Over 5000 happy students served. Click to find your next property.
Lukango — Lukango takes care of your insurance so you can focus on growing your business, knowing your dream is protected in the right way.
Klarytee — Klarytee is a SaaS platform that builds security into sensitive content to enable granular control wherever the data goes

Roger Hassan is the Founding Partner at Shorea Ventures.

Investment focus

Food and Beverage, Grocery, Medical
Seed, Angel, Pre-Seed
Germany, United Kingdom

Portfolio highlights

GetHalal — It's an online one-stop-shop for all Halal groceries, Halal fresh meat, fish, vegetables and fruits for all Muslims in Europe. We have multi-ordering channels, 24/7 customer support and offering 2nd-day delivery.
Tupu — Tupu engages in the manufacture and supply of mushroom-based foods.
getvoila — voilà is the Berlin-based company that enables people to enjoy fine dining experiences at home, with nationwide delivery.

Jim Mellon

Investment focus

Medical, Health Care, Pharmaceutical
Series A, Funding Round
United Kingdom

Portfolio highlights

Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.

Dieter Spälti, Swiss national, born in 1961, Member of the Board of Directors, Member of the Audit Committee, Member of the Governance & Strategy Committee since January 1, 2013. He studied law at the University of Zurich, obtaining a doctorate in 1989. He began his professional career as a credit officer with Bank of New York in New York,before taking up an appointment as CFO of Tyrolit (Swarovski Group), based in Innsbruck and Zurich, in 1991.From 1993 until 2001, he was with McKinsey & Company, ultimately as a partner, and was involved in numerous projects with industrial, financial and technology firms in Europe, the USA and Southeast Asia. In October 2002, he joined Rapperswil-Jona-based Spectrum Value Management Ltd. as a partner, the firm which administers the industrial and private investments of the family of Thomas Schmidheiny.Since 2006, he has been CEO of Spectrum Value Management Ltd. He was elected to the Board of Directors of Holcim Ltd in 2003.

Investment focus

Medical, Software, Health Care
Series A
United Kingdom

Portfolio highlights

Ultromics — Unlock the full potential of echocardiography with groundbreaking solution that simplifies echo reporting. Echo that is precise, fast and accurate.

Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.

Investment focus

Information Technology, SaaS, Medical
Seed, Pre-Seed
United Kingdom

Portfolio highlights

seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.

John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Angel, Series A
United Kingdom, United States

Portfolio highlights

LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
Worldr — Valarian | Innovating for the new era of digital sovereignty

Investors by industry

Artificial intelligence